IP Library Granted Patent US 12,186,567
Granted Patent B2
US 12,186,567 · App. 17/541,075 · Granted Jan 7, 2025

Ventricular blanking period after atrially sensed beats

Inventor: Jessica Burr (Boston, MA)
Assignee: Cardiac Pacemakers, Inc.
A61N1/365A61N1/36842
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,186,567
App. No.
17/541,075
Granted
Jan 7, 2025
Kind
B2
Abstract

Systems and methods are disclosed to determine, in response to a detected atrial sense event in a first cardiac cycle, a ventricular blanking period for the first cardiac cycle and to detect a ventricular sense event in the first cardiac cycle using the received electrical information following the determined ventricular blanking period.

Claims (48)

1. An implantable medical device, comprising:

a signal receiver circuit comprising:

a first channel configured to receive electrical information from an atrium of a heart of a patient for a first cardiac cycle; and

a second channel configured to receive electrical information from a His bundle location of a ventricle of the heart of the patient for the first cardiac cycle; and

an assessment circuit configured to:

detect an atrial sense event in the first cardiac cycle using the received electrical information from the first channel;

determine, in response to the detected atrial sense event in the first cardiac cycle, a ventricular blanking period for the first cardiac cycle; and

detect a ventricular sense event in the first cardiac cycle using the received electrical information from the second channel following the determined ventricular blanking period.

2. The implantable medical device of claim 1 , wherein the assessment circuit is configured to detect, in response to the detected atrial sense event in the first cardiac cycle, the ventricular sense event in the first cardiac cycle following the detected atrial sense event and the determined ventricular blanking period.

3. The implantable medical device of claim 1 , comprising:

a therapy circuit configured to generate a His bundle pacing pulse for delivery at or near a His bundle of the heart,

wherein the assessment circuit is configured to control delivery of the His bundle pacing pulse, including to initiate delivery of the His bundle pacing pulse in the first cardiac cycle after the detected atrial sense event by a timing parameter.

4. The implantable medical device of claim 1 , wherein the first channel comprises an atrial lead port,

wherein the second channel comprises a ventricular lead port,

wherein the assessment circuit is configured to determine the ventricular blanking period after a detected atrial sensed event while the implantable medical device is in a His bundle pacing mode to improve detection of ventricular events from the ventricular lead port, and

wherein the assessment circuit is configured to apply the determined ventricular blanking period to the second channel for the first cardiac cycle after the detected atrial sense event to avoid sensing a P-wave from the His bundle location of a right ventricle of the heart.

5. The implantable medical device of claim 1 , wherein the ventricular blanking period is a selectable time period, between 45 and 105 ms, after a detected atrial sense event.

6. The implantable medical device of claim 1 , wherein the assessment circuit is configured to detect the ventricular sense event in the first cardiac cycle after the detected atrial sense event and the determined ventricular blanking period to avoid sensing a P-wave from the His bundle location of a right ventricle of the heart.

7. A method comprising:

receiving electrical information from an atrium of a heart of a patient for a first cardiac cycle using a first channel of a signal receiver circuit;

receiving electrical information from a His bundle location of a ventricle of the heart of the patient for the first cardiac cycle using a second channel of the signal receiver circuit;

detecting, using an assessment circuit, an atrial sense event in the first cardiac cycle using the received electrical information from the first channel;

determining, using the assessment circuit, in response to the detected atrial sense event in the first cardiac cycle, a ventricular blanking period for the first cardiac cycle; and

detecting, using the assessment circuit, a ventricular sense event in the first cardiac cycle using the received electrical information from the second channel following the determined ventricular blanking period.

8. The method of claim 7 , wherein detecting the ventricular sense event comprises detecting, in response to the detected atrial sense event in the first cardiac cycle, the ventricular sense event in the first cardiac cycle following the detected atrial sense event and the determined ventricular blanking period.

9. The method of claim 7 , comprising:

generating, using a therapy circuit, a His bundle pacing pulse for delivery at or near a His bundle of the heart; and

controlling, using the assessment circuit, delivery of the His bundle pacing pulse, including initiating delivery of the His bundle pacing pulse in the first cardiac cycle after the detected atrial sense event by a timing parameter.

10. The method of claim 7 , wherein the first channel comprises an atrial lead port,

wherein the second channel comprises a ventricular lead port, and

wherein determining the ventricular blanking period includes determining the ventricular blanking period after a detected atrial sensed event while the assessment circuit is in a His bundle pacing mode to improve detection of ventricular events from the ventricular lead port.

11. The method of claim 7 , wherein the ventricular blanking period is a selectable time period, between 45 and 105 ms, after a detected atrial sense event.

12. The method of claim 7 , wherein detecting the ventricular sense event in the first cardiac cycle comprises detecting the ventricular sense event in the first cardiac cycle after the detected atrial sense event and the determined ventricular blanking period to avoid sensing a P-wave from the His bundle location of a right ventricle of the heart.

13. An implantable medical device, comprising:

a signal receiver circuit comprising:

a first channel configured to receive electrical information from an atrium of a heart of a patient for a first cardiac cycle; and

a second channel configured to receive electrical information from a His bundle location of a ventricle of the heart of the patient for the first cardiac cycle; and

an assessment circuit configured to:

detect an atrial sense event in the first cardiac cycle using the received electrical information from the first channel;

apply, in response to the detected atrial sense event in the first cardiac cycle, a ventricular blanking period to the second channel for the first cardiac cycle; and

detect a ventricular sense event in the first cardiac cycle using the received electrical information from the second channel following the applied ventricular blanking period.

14. The implantable medical device of claim 1 , wherein the atrial sense event is different than an atrial pace event.

15. The implantable medical device of claim 1 , wherein to determine the ventricular blanking period for the first cardiac cycle comprises to determine to apply the ventricular blanking period to the second channel responsive to the detected atrial sense event in the first cardiac cycle.

16. The implantable medical device of claim 15 , wherein the determination to apply the ventricular blanking period is determined using information only from the first cardiac cycle.

17. The implantable medical device of claim 15 , wherein to determine to apply the ventricular blanking period to the second channel is further responsive to an indication that the implantable medical device is in a His bundle pacing mode for the first cardiac cycle.

18. The method of claim 7 , wherein the atrial sense event is different than an atrial pace event.

19. The method of claim 7 , wherein determining the ventricular blanking period for the first cardiac cycle comprises determining to apply the ventricular blanking period to the second channel responsive to the detected atrial sense event in the first cardiac cycle.

20. The method of claim 19 , wherein determining to apply the ventricular blanking period comprises using information only from the first cardiac cycle.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2021
From: BURR, JESSICA
To: CARDIAC PACEMAKERS, INC.
Reel/Frame 058274/0919 →
Continuity (2)
Provisional Application 63120607 · Dec 2, 2020
Related Publication 20220168566A1 · Jun 2, 2022
References Cited (101)
US 4548203A · Tacker, Jr. et al. · 1985 [cited by applicant]
US 4559946A · Mower · 1985 [cited by applicant]
US 4637397A · Jones et al. · 1987 [cited by applicant]
US 4641656A · Smits · 1987 [cited by applicant]
US 4693253A · Adams · 1987 [cited by applicant]
US 4708145A · Tacker, Jr. et al. · 1987 [cited by applicant]
US 4763646A · Lekholm · 1988 [cited by applicant]
US 4774952A · Smits · 1988 [cited by applicant]
US 4775950A · Terada et al. · 1988 [cited by applicant]
US 4787389A · Tarjan · 1988 [cited by applicant]
US 4788980A · Mann et al. · 1988 [cited by applicant]
US 4800883A · Winstrom · 1989 [cited by applicant]
US 4821723A · Baker, Jr. et al. · 1989 [cited by applicant]
US 4827932A · Ideker et al. · 1989 [cited by applicant]
US 4834100A · Charms · 1989 [cited by applicant]
US 4944300A · Saksena · 1990 [cited by applicant]
US 4984572A · Cohen · 1991 [cited by applicant]
US 4996984A · Sweeney · 1991 [cited by applicant]
US 5007422A · Pless et al. · 1991 [cited by applicant]
US 5085213A · Cohen · 1992 [cited by applicant]
US 5111812A · Swanson et al. · 1992 [cited by applicant]
US 5154485A · Fleishman · 1992 [cited by applicant]
US 5161528A · Sweeney · 1992 [cited by applicant]
US 5163428A · Pless · 1992 [cited by applicant]
US 5178140A · Ibrahim · 1993 [cited by applicant]
US 5265600A · Adams et al. · 1993 [cited by applicant]
US 5275621A · Mehra · 1994 [cited by applicant]
US 5282836A · Kreyenhagen et al. · 1994 [cited by applicant]
US 5350401A · Levine · 1994 [cited by applicant]
US 5366485A · Kroll et al. · 1994 [cited by applicant]
US 5431682A · Hedberg · 1995 [cited by applicant]
US 5441521A · Hedberg · 1995 [cited by applicant]
US 5464429A · Hedberg et al. · 1995 [cited by applicant]
US 5489293A · Pless et al. · 1996 [cited by applicant]
US 5522853A · Kroll · 1996 [cited by applicant]
US 5928271A · Hess et al. · 1999 [cited by applicant]
US 5978707A · Krig et al. · 1999 [cited by applicant]
US 6067471A · Warren · 2000 [cited by applicant]
US 6718206B2 · Casavant · 2004 [cited by applicant]
US 7738954B1 · Kroll et al. · 2010 [cited by applicant]
US 8588907B2 · Arcot-Krishnamurthy et al. · 2013 [cited by applicant]
US 11071866B2 · Casavant et al. · 2021 [cited by applicant]
US 11458319B2 · Casavant et al. · 2022 [cited by applicant]
US 11918814B2 · Casavant et al. · 2024 [cited by applicant]
US 20020120318A1 · Kroll et al. · 2002 [cited by applicant]
US 20060224193A1 · Hess · 2006 [cited by applicant]
US 20070055184A1 · Echt et al. · 2007 [cited by applicant]
US 20110264158A1 · Dong et al. · 2011 [cited by applicant]
US 20110307026A1 · Zhu et al. · 2011 [cited by applicant]
US 20110319956A1 · Zhu et al. · 2011 [cited by applicant]
US 20130158621A1 · Ding et al. · 2013 [cited by applicant]
US 20140107724A1 · Shuros et al. · 2014 [cited by applicant]
US 20140172035A1 · Shuros et al. · 2014 [cited by applicant]
US 20160213272A1 · Pujar · 2016 [cited by applicant]
US 20170120058A1 · Ghosh et al. · 2017 [cited by applicant]
US 20190126049A1 · Casavant et al. · 2019 [cited by applicant]
US 20190126050A1 · Shuros et al. · 2019 [cited by applicant]
US 20200009380A1 · Casavant et al. · 2020 [cited by applicant]
US 20210052895A1 · Lybarger · 2021 [cited by examiner]
US 20230001199A1 · Casavant et al. · 2023 [cited by applicant]
US 20240157153A1 · Casavant et al. · 2024 [cited by applicant]
CN 107405492A · 2017 [cited by applicant]
CN 107847747A · 2018 [cited by applicant]
CN 112543662A · 2021 [cited by applicant]
EP 0467652 · 1992 [cited by applicant]
EP 0588124 · 1994 [cited by applicant]
EP 3817805B1 · 2022 [cited by applicant]
WO WO9528987A1 · 1995 [cited by applicant]
WO WO9528988A1 · 1995 [cited by applicant]
WO WO9701373A1 · 1997 [cited by applicant]
WO WO2014099595A2 · 2014 [cited by applicant]
WO WO2019079454A1 · 2019 [cited by applicant]
WO WO2020010001A1 · 2020 [cited by applicant]
U.S. Appl. No. 08/720,360 U.S. Pat. No. 5,797,967, filed Sep. 27, 1996, System and Method to Reduce Defibrillation Requirements. [cited by applicant]
U.S. Appl. No. 16/459,092, filed Jul. 1, 2019, Adjustable Sensing in a His-Bundle Pacemaker. [cited by applicant]
“U.S. Appl. No. 16/459,092, Examiner Interview Summary mailed May 10, 2021”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 16/459,092, Non Final Office Action mailed Feb. 18, 2021”, 16 pgs. [cited by applicant]
“U.S. Appl. No. 16/459,092, Non Final Office Action mailed Jul. 27, 2021”, 16 pgs. [cited by applicant]
“U.S. Appl. No. 16/459,092, Response filed May 17, 2021 to Non Final Office Action mailed Feb. 18, 2021”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 16/459,092, Response filed Oct. 27, 2021 to Non Final Office Action mailed Jul. 27, 2021”, 10 pgs. [cited by applicant]
“International Application Serial No. PCT/US2019/040144, International Preliminary Report on Patentability mailed Jan. 21, 2021”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT/US2019/040144, International Search Report mailed Sep. 26, 2019”, 5 pgs. [cited by applicant]
“International Application Serial No. PCT/US2019/040144, Written Opinion mailed Sep. 26, 2019”, 5 pgs. [cited by applicant]
Allessie, M, et al., “Regional Control of Atrial Fibrillation by Rapid Pacing in Conscious Dogs”, Circulation, 84(4), (Oct. 1991), 1689-1697. [cited by applicant]
Ayers, Gregory M., et al., “Ventricular Proarrhythmic Effects of Ventricular Cycle Length and Shock Strength in a Sheep Model of Transvenous Atrial Defibrillation”, Circulation, 89 (1), (Jan. 1994), 413-422. [cited by applicant]
Burri, Haran, et al., “Device Programming for His Bundle Pacing”, Circulation: Arrhythmia and Electrophysiologyvol. 12, Issue 2, Feb. 2019 https://doi.org/10.1161/CIRCEP.118.006816, 11 pgs. [cited by applicant]
Dillon, S M., “Synchronized Repolarization After Defibrillation Shocks”, Circulation, 85(5), (May 1992), 1865-1878. [cited by applicant]
Frazier, D W., et al., “Stimulus-Induced Critical Point-Mechanism for Electrical Initiation of Reentry in Normal Canine Myocardium”, Journal of Clinical Investigation, 83, (Mar. 1989), 1039-1052. [cited by applicant]
Kenknight, B H., et al., “Regional Capture of Fibrillating Ventricular Myocardium”, Circulation Research, 77(4), (Oct. 1995), 849-855. [cited by applicant]
Tang, A S., et al., “Three-Dimensional Potential Gradient Fields Generated by Intracardiac Catheter and Cutaneous Patch Electrodes”, Circulation, 85 (5), (May 1992), 1857-1864. [cited by applicant]
Wharton, J M., et al., “Cardiac Potential and Potential Gradient Fields Generated by Single, Combined, and Sequential Shocks During Ventricular Defibrillation”, Circulation, 85 (4), (Apr. 1992), pp. 1510-1523. [cited by applicant]
“U.S. Appl. No. 16/459,092, Final Office Action mailed Feb. 1, 2022”, 18 pgs. [cited by applicant]
“U.S. Appl. No. 16/459,092, Notice of Allowance mailed May 31, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/459,092, Response filed Mar. 31, 2022 to Final Office Action mailed Feb. 1, 2022”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 17/940,886, Non Final Office Action mailed Mar. 31, 2023”, 20 pgs. [cited by applicant]
“U.S. Appl. No. 17/940,886, Notice of Allowance mailed Oct. 25, 2023”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 17/940,886, Response filed Jun. 28, 2023 to Non Final Office Action mailed Mar. 31, 2023”, 12 pgs. [cited by applicant]
“Chinese Application Serial No. 201980045473.4, Office Action mailed Jan. 23, 2024”, w/o English Translation, 9 pgs. [cited by applicant]
“Chinese Application Serial No. 201980045473.4, Response filed May 21, 2024 to Office Action mailed Jan. 23, 2024”, w/ current English claims, 15 pgs. [cited by applicant]
Dhingra, R C, et al., “Significance of the HV interval in 517 patients with chronic bifascicular block”, Circulation. 64(6), (1981), 1265-71. [cited by applicant]
Habel, N., et al., “Atrial Oversensing and Optimizing His Bundle Lead Position”, In: Natale A., Wang P., Al-Ahmad A., Estes N. (eds) Cardiac Electrophysiology. Springer, Cham., (2020), 569-571. [cited by applicant]